Mylan (MYL) Sued by Shareholder Over EpiPen Payments

October 11, 2016 12:12 PM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Mylan (NASDAQ: MYL) shares are on watch after an investor sued the company over allegations that it made misstatements on payments made to government health-insurance programs with respect to its EpiPen product, according to Bloomberg.

The lawsuit was filed in Manhattan court Tuesday.

Shares of Mylan are down around 1 percent.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog, Litigation

Add Your Comment